Perforating dermatosis in a patient receiving bevacizumab

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 8, 2009, Pages 972-974

  Vano Galvan, S ^a   Moreno, C ^a   Medina, J ^a   Perez Garcia B ^a   Garcia Lopez J L ^a   Jaen P ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; VASCULOTROPIN;

ADULT; ANTIANGIOGENIC ACTIVITY; BLEEDING; CANCER STAGING; CASE REPORT; COLORECTAL CANCER; DIGESTIVE SYSTEM PERFORATION; DRUG TOLERABILITY; EXFOLIATIVE DERMATITIS; HUMAN; HYPERTENSION; LETTER; LIVER METASTASIS; LOADING DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; PERFORATING DERMATOSIS; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RASH; SKIN BIOPSY; SKIN DISEASE; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT RESPONSE; WOUND HEALING IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SKIN DISEASES; TREATMENT OUTCOME;

EID: 67651152971     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03078.x     Document Type: Letter

References (6)

1. Homsi J, Daud AI. Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors. Cancer Control 2007 14 : 285 294.
2. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004 350 : 2335 2342.
3. Gotlib V, Khaled S, Lapko I, Mar N, Saif MW. Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response. Anticancer Drugs 2006 17 : 1227 1229.
4. Hinrichs W, Breuckmann F, Altmeyer P, Kreuter A. Acquired perforating dermatosis: a report on 4 cases associated with scabies infection. J Am Acad Dermatol 2004 51 : 665 667.
5. Fernández-Guarino M, Aldanondo I, González-García C et al. Gefitinib-induced perforating dermatosis. Actas Dermosifiliogr 2006 97 : 208 211.
6. Kawakami T, Saito R. Acquired reactive perforating collagenosis associated with diabetes mellitus: eight cases that meet Faver's criteria. Br J Dermatol 1999 140 : 521 524.